Stock Comparison

ABT vs ZBH

Abbott Laboratories and Zimmer Biomet Holdings Inc side by side — valuation, profitability, growth and risk.

Valuation

Market Cap
$163.94B
$18.01B
P/E (TTM)
26.4
24.1
Forward P/E
17.2
11.2
Price/Sales
3.6
2.1
Price/Book
3.2
1.4
EV/EBITDA
16.1
10.9
Dividend Yield
2.62%
1.06%

Profitability

Net Margin
13.90%
9.05%
Operating Margin
13.50%
19.70%
Return on Equity
12.30%
6.07%
Return on Assets
5.59%
4.10%

Growth (YoY)

Revenue Growth
7.80%
9.30%
Earnings Growth
-19.70%
34.10%

Price & Risk

Beta
0.6
0.5
52-Week High
$135.34
$107.16
52-Week Low
$81.97
$78.91
Analyst Target
$116.54
$98.70

Compare ABT and ZBH your own way

Try mrmarket.ai free

Figures are sourced from company filings and market data and may be delayed or revised. For informational purposes only — not investment advice.